...
机译:硫嘌呤治疗和硫嘌呤 - 未经处理的炎症性肠病患者皮肤癌的风险:系统审查和荟萃分析
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
The First School of Clinical MedicineSouthern Medical UniversityGuangzhou Guangdong China;
Basic Medical CollegeSouthern Medical UniversityGuangzhou Guangdong China;
Department of Plastic Surgery Changhai HospitalSecond Military Medical UniversityShanghai China;
Basic Medical CollegeNavy Medical UniversityShanghai China;
Department of Gastroenterology Guangdong General Hospital and Guangdong Academy of Medical;
immunosuppressant; inflammatory bowel disease; melanoma skin cancer; nonmelanoma skin cancer; skin cancer; thiopurines;
机译:硫嘌呤治疗和硫嘌呤 - 未经处理的炎症性肠病患者皮肤癌的风险:系统审查和荟萃分析
机译:染素治疗炎症性肠病患者的非母瘤皮肤癌症风险:对文献的系统审查
机译:具有meta分析的系统评价:硫嘌呤降低炎症性肠病患者结肠直肠瘤形成的风险
机译:炎症性肠疾病中结直肠癌风险的患者
机译:荟萃分析:TPMT基因变异等位基因对硫嘌呤诱导的毒性的影响
机译:炎症性肠病患者硫嘌呤S-甲基转移酶多态性与硫嘌呤诱导的不良药物反应之间的关联:荟萃分析
机译:炎症性肠病患者中硫嘌呤s-甲基转移酶基因多态性与硫嘌呤诱导的药物不良反应的关联:荟萃分析。